The Latest Cardiac and Vascular News
ST. LOUIS, March 04, 2019 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2018 fourth quarter and full year ended December 31, 2018 on Tuesday, March 12, 2019 […]
EDEN PRAIRIE, Minn., March 01, 2019 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ: CHFS), today announced that effective February 25, 2019, the independent directors approved five equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to five individuals entering into employment with the Company. The equity awards […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and related conditions, today announced fourth quarter and full year 2018 financial results. “We are pleased with our fourth quarter performance, capping a year of strong, consistent revenue growth,” said Mike Carrel, President and Chief Executive […]
MONTREAL–(BUSINESS WIRE)–Christian Weber, PhD, MD, Chair of Preventative Vascular Medicine and Director of theInstitute for Cardiovascular Prevention at Ludwig‐Maximilians University (LMU) Munich, Germany, joins the Clinical Advisory Board (CAB) of Mperia Therapeutics Inc. “Dr Weber is that rarity: an eminent practicing cardio-vascular clinician who also has unparalleled research experience and has published key papers […]
MALVERN, Pa., Feb. 28, 2019 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today the election of Laura Dietch and Tiffany Olson to BioTelemetry’s Board of Directors. Ms. […]
REDWOOD CITY, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announced that it will release its financial results for the fourth […]
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of serious cardiovascular diseases, today reported financial results for the fourth quarter and full year ended December 31, 2018. “2018 was MyoKardia’s most significant […]
WESTMINSTER, Colo., Feb. 27, 2019 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today reported financial results for the year ended December 31, 2018 and provided a corporate update. “During 2018, we continued to make […]
ENGLEWOOD, Colo., Feb. 28, 2019 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced it has hired Christopher A. Brown as its Vice President of Sales and Marketing. Chris Brown has spent his […]
SAN RAMON, Calif., Feb. 28, 2019 /PRNewswire/ — BioVentrix, Inc., a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced a significant reimbursement achievement. InEk, the German Institute for Hospital Remuneration, has reconfirmed the award of NUB Status 1 for the Revivent TC™ TransCatheter Ventricular Enhancement System. […]
